Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolomod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation.
Effects of prophylactic and therapeutic teriflunomide in transcranial magnetic stimulation-induced motor-evoked potentials in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.
Complexity of trophic factor signaling in experimental autoimmune encephalomyelitis: Differential expression of neurotrophic and gliotrophic factors.
TGN1412: From Discovery to Disaster.
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial.
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
[Results of a comparative clinical trial of the Russian Β - interferon-1b bioanalogue (infibeta)].
Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke.
TGFβ Signaling Regulates the Timing of CNS Myelination by Modulating Oligodendrocyte Progenitor Cell Cycle Exit through SMAD3/4/FoxO1/Sp1.
Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
Roche's MabThera approved for two vasculitis indications in UK
RILUTEK®
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon Beta 1a dosages for multiple sclerosis.
Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy.
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI.
European Medicines Agency
Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.

Pages